CannTrust Holdings (TSX:TRST): Buy the Dip or Jump Ship?

Should you buy CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) amid the scandal?

Road sign warning of a risk ahead

Image source: Getty Images.

CannTrust Holdings (TSX:TRST)(NYSE:CTST) has crashed by so much that it has a valuation that’s not cringe-worthy. Even after a +80% fall over the illicit cannabis-growth fiasco, the stock isn’t exactly what you’d consider cheap, but as far as cannabis stocks are concerned, it’s the closest thing you’ll find to a steal.

While CannTrust may be subject to penalties, I think the decline is excessive. If it were any industry other than cannabis, the fall probably would have been capped at a 40% drop. So, in essence, the recent nosediving in shares may prove to be a massive bargain in a year or two down the road, when everybody has forgotten about CannTrust’s illicit cannabis cultivation in an unlicensed room.

While CannTrust is still a speculative bet, I think there are significant rewards for those willing to take the risk.

Jefferies pointed out that a major management shuffle may be on the horizon, which would likely improve the odds that CannTrust won’t get its licence ripped up by Health Canada amid its sales suspension.

At the time of writing, the company is under a Health Canada investigation that’s expected to “conclude within a few days” with “appropriate actions [taken] immediately after.”

There’s no question that CannTrust will be a major double-digit mover in the week ahead, and although things seem dire, it’s noteworthy that most investors have been acting on speculation, not facts, as fellow Fool contributor David Jagielski pointed out in his piece on the CannTrust fiasco: “Many people have been jumping to conclusions and speculating on what may or may not happen, which has just made matters worse for the stock, as there’s nothing like mass panic to send a stock into a tailspin.”

An everything-or-nothing scenario

Depending on what Health Canada decides to do, CannTrust could either skyrocket into the stratosphere or move closer to zero.

If CannTrust has its licence suspended, there will be much more selling, and you’ll probably lose your entire investment in the name. In any other scenario, CannTrust could be a quick triple, especially if there are only fines, firings, and corrective actions involved.

In any case, I think that management has learned their lesson the hard way. I suspect the company will face a soured upcoming quarter, but I don’t think the company will be left for dead — a scenario many investors seem to be buying into. After its +80% plunge, I’d say the lousy quarter is baked in many times over.

Furthermore, Jagielski brought up a good point in that the government wants the industry to succeed, and a licence suspension, which could stunt investment across the broader industry, is not a reasonable course of action.

I think CannTrust is a solid buy on the dip but only for those with excess cash that they wouldn’t mind losing entirely.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »